File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Sustained improvement in diabetic control on long-term self-monitoring of blood glucose

TitleSustained improvement in diabetic control on long-term self-monitoring of blood glucose
Authors
Issue Date1986
PublisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/diabres
Citation
Diabetes Research And Clinical Practice, 1986, v. 2 n. 3, p. 165-171 How to Cite?
AbstractThe benefits of self-monitoring of blood glucose (SMBG) were assessed in 38 Chinese adults on conventional insulin regimens who had been performing SMBG for a mean duration of 26 months (range 15-40). For analysis patients were divided into 2 groups. Group A consisted of 27 insulin-requiring patients who were referred for SMBG because of poor control or young age (≤35 years). Group B consisted of 11 IDDM patients who were on SMBG from diagnosis. Mean age and duration of SMBG were similar in the 2 groups though group A had longer duration of disease. In group A, mean haemoglobin A 1 (HbA 1) decreased from 12.4 ± 0.5% before SMBG to 10.9 ± 0.5% at 6 months (P < 0.005), 10.7 ± 0.5% at 12 months (P < 0.005) and 10.3 ± 0.4% after long-term SMBG. This was accompanied by a significant reduction in insulin requirement from 0.82 ± 0.07 U/kg/day to 0.72 ± 0.07 U/kg/day (P < 0.05). In group B, insulin requirement progressively decreased in the first 6 months. At 12 months, mean HbA 1 was 9.0 ± 0.5% and insulin requirement was 0.58 ± 0.08 U/kg/day. No significant change in HbA 1 or insulin requirement was observed beyond the first year. After long-term SMBG, 82% of patients in group B had good control (HbA 1 ≤ 10%) compared to 45% only in group A (P < 0.05). Long-term SMBG is associated with sustained improvement in diabetic control and is particularly beneficial if introduced to diabetic patients right from diagnosis.
Persistent Identifierhttp://hdl.handle.net/10722/161711
ISSN
2015 Impact Factor: 3.045
2015 SCImago Journal Rankings: 1.338

 

DC FieldValueLanguage
dc.contributor.authorLam, KSLen_US
dc.contributor.authorMa, JTCen_US
dc.contributor.authorChan, EYMen_US
dc.contributor.authorYeung, RTTen_US
dc.date.accessioned2012-09-05T05:14:15Z-
dc.date.available2012-09-05T05:14:15Z-
dc.date.issued1986en_US
dc.identifier.citationDiabetes Research And Clinical Practice, 1986, v. 2 n. 3, p. 165-171en_US
dc.identifier.issn0168-8227en_US
dc.identifier.urihttp://hdl.handle.net/10722/161711-
dc.description.abstractThe benefits of self-monitoring of blood glucose (SMBG) were assessed in 38 Chinese adults on conventional insulin regimens who had been performing SMBG for a mean duration of 26 months (range 15-40). For analysis patients were divided into 2 groups. Group A consisted of 27 insulin-requiring patients who were referred for SMBG because of poor control or young age (≤35 years). Group B consisted of 11 IDDM patients who were on SMBG from diagnosis. Mean age and duration of SMBG were similar in the 2 groups though group A had longer duration of disease. In group A, mean haemoglobin A 1 (HbA 1) decreased from 12.4 ± 0.5% before SMBG to 10.9 ± 0.5% at 6 months (P < 0.005), 10.7 ± 0.5% at 12 months (P < 0.005) and 10.3 ± 0.4% after long-term SMBG. This was accompanied by a significant reduction in insulin requirement from 0.82 ± 0.07 U/kg/day to 0.72 ± 0.07 U/kg/day (P < 0.05). In group B, insulin requirement progressively decreased in the first 6 months. At 12 months, mean HbA 1 was 9.0 ± 0.5% and insulin requirement was 0.58 ± 0.08 U/kg/day. No significant change in HbA 1 or insulin requirement was observed beyond the first year. After long-term SMBG, 82% of patients in group B had good control (HbA 1 ≤ 10%) compared to 45% only in group A (P < 0.05). Long-term SMBG is associated with sustained improvement in diabetic control and is particularly beneficial if introduced to diabetic patients right from diagnosis.en_US
dc.languageengen_US
dc.publisherElsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/diabresen_US
dc.relation.ispartofDiabetes Research and Clinical Practiceen_US
dc.subject.meshAdulten_US
dc.subject.meshBlood Glucose - Analysisen_US
dc.subject.meshDiabetes Mellitus, Type 1 - Blood - Drug Therapyen_US
dc.subject.meshDiabetes Mellitus, Type 2 - Blooden_US
dc.subject.meshDiabetic Retinopathy - Blooden_US
dc.subject.meshEvaluation Studies As Topicen_US
dc.subject.meshFemaleen_US
dc.subject.meshHemoglobin A, Glycosylated - Analysisen_US
dc.subject.meshHumansen_US
dc.subject.meshInsulin - Therapeutic Useen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshMonitoring, Physiologicen_US
dc.subject.meshSelf Careen_US
dc.subject.meshTime Factorsen_US
dc.titleSustained improvement in diabetic control on long-term self-monitoring of blood glucoseen_US
dc.typeArticleen_US
dc.identifier.emailLam, KSL:ksllam@hku.hken_US
dc.identifier.authorityLam, KSL=rp00343en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid3527625-
dc.identifier.scopuseid_2-s2.0-0022832043en_US
dc.identifier.volume2en_US
dc.identifier.issue3en_US
dc.identifier.spage165en_US
dc.identifier.epage171en_US
dc.publisher.placeIrelanden_US
dc.identifier.scopusauthoridLam, KSL=8082870600en_US
dc.identifier.scopusauthoridMa, JTC=24491943700en_US
dc.identifier.scopusauthoridChan, EYM=7401994095en_US
dc.identifier.scopusauthoridYeung, RTT=7102833337en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats